<DOC>
	<DOCNO>NCT00002386</DOCNO>
	<brief_summary>The purpose study see indinavir plus two anti-HIV drug affect blood clot HIV-positive patient hemophilia .</brief_summary>
	<brief_title>Effect Indinavir Plus Two Other Anti-HIV Drugs Blood Clotting HIV-Positive Males With Hemophilia</brief_title>
	<detailed_description>Patients enrol one two study group . The treatment group consist HIV-1 seropositive patient hemophilia A B protease-inhibitor naive . The laboratory control group consist HIV-1 seropositive patient hemophilia A stable , triple-combination antiretroviral regimen . Patients treatment group receive indinavir sulfate plus two follow NRTIs : zidovudine ( ZDV ) , didanosine ( ddI ) , zalcitabine ( ddC ) , stavudine ( d4T ) , lamivudine ( 3TC ) . Patients treatment group preferably naive one NRTIs . Patients laboratory control group continue stable triple antiretroviral regimen consist protease inhibitor plus two NRTIs . Patients control group provide antiretroviral medication part study . Patients treatment group evaluate physical examination , safety laboratory test , CD4 cell count , viral load Day 1 Weeks 2 , 4 , 8 , 12 every 8 week Week 52 . Patients control group evaluate physical examination , safety laboratory test , CD4 cell count , viral load Day -1 Week 12 . All patient receive usual factor concentrate infusion 10-minute period Day -1 Week 12 estimate factor VIII ( IX ) recovery half-life . Blood sample take prior infusion 30 minute 1 , 3 , 6 , 9 , 12 , 24 hour infusion . All patient require keep daily log document bleed episode use factor VIII ( IX ) throughout study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Zalcitabine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are HIVpositive male . Have diagnose hemophilia . Have take clot factor hemophilia least 6 month . Have take combination one protease inhibitor plus two antiHIV drug least 6 month , never take protease inhibitor . Are least 16 year old ( consent parent guardian require 18 ) .</criteria>
	<gender>Male</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1999</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Indinavir</keyword>
	<keyword>Factor VIII</keyword>
	<keyword>Factor IX</keyword>
	<keyword>Half-Life</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Platelet Aggregation</keyword>
	<keyword>Hemophilia A</keyword>
	<keyword>Hemophilia B</keyword>
</DOC>